Literature DB >> 6721611

Inhibition of Leishmania amastigote growth by antipain and leupeptin.

G H Coombs, J Baxter.   

Abstract

Antipain and leupeptin were found to be potent inhibitors of the growth of Leishmania mexicana mexicana amastigotes in explanted mouse unstimulated peritoneal macrophages. Antipain at 100 mg l-1 reduced eight-fold the percentage of macrophages infected and to 5% of the control the number of amastigotes present after seven days incubation. At 1 mg l-1, antipain and leupeptin were as effective antileishmanial agents as pentamidine isethionate, all three stopping parasite multiplication over the seven-day incubation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721611     DOI: 10.1080/00034983.1984.11811768

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  11 in total

1.  Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.

Authors:  V J Chan; P M Selzer; J H McKerrow; J A Sakanari
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  A cathepsin L-like cysteine proteinase gene from the protozoan parasite, Cryptobia salmositica.

Authors:  Palmy R R Jesudhasan; Chung-Wei Tan; Nikos Hontzeas; Patrick T K Woo
Journal:  Parasitol Res       Date:  2006-11-17       Impact factor: 2.289

3.  Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors.

Authors:  J C Mottram; A E Souza; J E Hutchison; R Carter; M J Frame; G H Coombs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis.

Authors:  Sukriti Goyal; Sonam Grover; Jaspreet Kaur Dhanjal; Manisha Goyal; Chetna Tyagi; Sajeev Chacko; Abhinav Grover
Journal:  J Mol Model       Date:  2014-02-25       Impact factor: 1.810

5.  Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.

Authors:  Alicia Ponte-Sucre; Radim Vicik; Martina Schultheis; Tanja Schirmeister; Heidrun Moll
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

6.  Cysteine protease inhibitors as chemotherapy: lessons from a parasite target.

Authors:  P M Selzer; S Pingel; I Hsieh; B Ugele; V J Chan; J C Engel; M Bogyo; D G Russell; J A Sakanari; J H McKerrow
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8.

Authors:  M Colmenares; M Tiemeyer; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors:  L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.

Authors:  S Rafati; S Couty-Jouve; M H Alimohammadian; J A Louis
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

10.  Ultrastructural and cytochemical identification of megasome in Leishmania (Leishmania) chagasi.

Authors:  Sanny O Alberio; Suzana S Dias; Flávio P Faria; Renato A Mortara; Clara L Barbiéri; Edna Freymüller Haapalainen
Journal:  Parasitol Res       Date:  2004-01-09       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.